Abstract:Background. Cerebral ischemia-reperfusion (I/R) injury is the main cause of acute brain injury, which is a life-threatening disease due to the lack of effective treatments. [D-Ala2, D-Leu5] enkephalin (DADLE) is a synthetic delta-opioid receptor agonist that is reported to confer neuroprotective effect; however, the underlying mechanism is still being explored. The purpose of the present study is to determine whether DADLE administrated intracerebroventricularly could attenuate the cerebral I/R injury, to determine if this is through inhibiting the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway and therefore inhibiting neuroinflammation in an ischemic stroke model. Methods. Rats were subjected to 120 minutes of ischemia by transient middle cerebral artery occlusion (MCAO). At 45 minutes after ischemia, DADLE or control vehicle (artificial cerebrospinal fluid, ACSF) was given to the rats intracerebroventricularly. Neurological deficit, cerebral infarct volume, and histopathological changes were assessed at 24 hours after reperfusion. Brain inflammation was assessed by measuring tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the ischemic penumbra by ELISA. The expression of TLR4 was determined by immunohistochemistry staining and western blotting. The expression of NF-κB was investigated by western blotting. Results. Compared with the vehicle-treatment (ACSF), DADEL improved neurological deficit (9.6±2.1 versus 13.8±1.9), reduced cerebral infarct volume (18.74±3.30% versus 10.57±2.50%), and increased the number of normal neurons (29.72±8.53% versus 51.37±9.18%) after cerebral I/R injury in rats (all P<0.05). Expressions of inflammatory molecules including TNF-α and IL-6 were highly expressed in the vehicle-treated rats, whereas treatment with DADLE downregulated these expressions (P<0.05). Additionally, cerebral I/R injury significantly increased the TLR4 and NF-κB expression in vehicle-control group, which was markedly inhibited by DADLE (P<0.05). Conclusions. DADLE, administrated intracerebroventricularly at 45 minutes after cerebral ischemia, significantly ameliorated I/R-induced brain damage in rats. This kind of neuroprotective effect appears to be related to the downregulation of TLR4-mediated inflammatory responses.

Enmein Decreases Synaptic Glutamate Release and Protects against Kainic Acid-Induced Brain Injury in Rats

Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats.

Inhibition of Synaptic Glutamate Exocytosis and Prevention of Glutamate Neurotoxicity by Eupatilin from Artemisia argyi in the Rat Cortex

Anti-Seizure and Neuronal Protective Effects of Irisin in Kainic Acid-Induced Chronic Epilepsy Model with Spontaneous Seizures

Lysosomal Enzyme Cathepsin B is Involved in Kainic Acid-Induced Excitotoxicity in Rat Striatum

Inhibition of nitric oxide production and protein tyrosine nitration contribute to neuroprotection by a novel calmodulin antagonist, DY-9760e, in the rat microsphere embolism.

Silymarin Inhibits Glutamate Release and Prevents against Kainic Acid-Induced Excitotoxic Injury in Rats

Kainic Acid-Induced Neurotoxicity: Targeting Glial Responses and Glia-Derived Cytokines

[D-Ala2, D-Leu5] Enkephalin Inhibits TLR4/NF-κB Signaling Pathway and Protects Rat Brains Against Focal Ischemia-Reperfusion Injury

Ursolic acid inhibits the synaptic release of glutamate and prevents glutamate excitotoxicity in rats

Neuroprotection of Tat-GluR6-9c Against Neuronal Death Induced by Kainate in Rat Hippocampus Via Nuclear and Non-nuclear Pathways*

An Anthranilate Derivative Inhibits Glutamate Release and Glutamate Excitotoxicity in Rats

Effect of L-arginine on expression of GFAP in kainic acid-induced seizure

Down-regulation of GluR2 is associated with Ca2+-dependent protease activities in kainate-induced apoptotic cell death in culturd rat hippocampal neurons

Neuroprotection Of Ischemic Postconditioning By Downregulating The Postsynaptic Signaling Mediated By Kainate Receptors

Enolase1 Alleviates Cerebral Ischemia-Induced Neuronal Injury Via Its Enzymatic Product Phosphoenolpyruvate

EDT,a Tetrahydroacridine Derivative Inhibits Cerebral Ischemia and Protects Rat Cortical Neurons Against Glutamate-Induced Cytotoxicity

A prosaposin-derived Peptide alleviates kainic Acid-induced brain injury

Echinocystic Acid, a Natural Plant Extract, Alleviates Cerebral Ischemia/reperfusion Injury Via Inhibiting the JNK Signaling Pathway

Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1/TLR4/NF‐κB network